Collaborating Centres
ANNUAL REPORT
Folder eCC_00015745 is in stage Annual_Report_Due
Name of the University, Hospital, Research Institute, Academy or Ministry
National Center for Global Health and Medicine
Name of the Division, Department, Unit, Section or Area
Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital
Reference Number

JPN-94

City

Shinjuku-ku

Title

WHO Collaborating Centre for Prevention, Preparedness and Response to Emerging
Infectious Diseases

Report Year04-2019 to 04-2020

1. Annual report on the agreed workplan
Describe progress made on the agreed workplan. For each activity, detail (1) the actions taken, (2) the
outputs delivered, as well as (3) any difficulties that may have been encountered. Three responses are
expected. [maximum 200 words per activity]. Indicate, if an activity has been completed previously,
has not yet started or has been placed on hold.
Activity 1
Title: To provide policy and technical advice to WHO and Member States in implementation of APSED
Description: The proposed institution will provide technical advice on the planning and implementation of IPC
and clinical management components (Focus Area 5: Prevention through Healthcare) of the Asia PacificStrategy for Emerging Diseases and Public Health Emergencies (APSED III) via APSED Technical Advisory
Group (TAG) meeting, regional consultations/meetings and country visits.
Status: ongoing
Dr. Norio OHMAGARI attended the Meeting of the Technical Advisory Group on the Asia Pacific Strategy for
Emerging Diseases and Public Health Emergencies (APSED lll): Advancing Implementation of theInternational Health Regulations (IHR) (2005) at the request of the World Health Organization (WHO) (June24-27, 2019, Manila, Philippines). At the meeting, he provided technical advice on the planning andimplementation of infection prevention and control (IPC) and clinical management components.
Activity 2
Title: To provide in-country training and technical advice on infection prevention and control (IPC) and clinicalmanagement of emerging infectious diseases (EIDs)
Description: The proposed institution will provide training and technical advice on IPC or clinical managementof emerging infectious disease such as EVD, MERS, Dengue fever and Zika virus disease and antimicrobial
resistant infections, in collaboration with WHO, National Institute of Infectious Diseases in Japan (NIID) andspecialist from Asia Pacific Region, via in-country visits and on-line meetings. Through this activity, NCGM willcontribute to strengthen IPC or clinical management of emerging infectious disease as a major component of
national preparedness in the region.

5/19/2020 7:09:17 AM

Page (1/5)

Collaborating Centres
ANNUAL REPORT
Status: ongoing
Dr. Norio OHMAGARI attended the IPC meeting in Bach Mai Hospital (June 5-7, 2019, Hannoi, Vietnam). At
the meeting, he provided technical advice on the planning and implementation of IPC and clinicalmanagement components to approximately 100 Health Care Workers (HCWs). In addition, he attended the
IPC meeting in Sulilanti Saroso Infectious Diseases Hospital (August 7-9, 2019, Jakarta, Indonesia), wherein
he provided technical advice on the planning and implementation of IPC and clinical management
components to approximately 50 HCWs.
Dr. Satoshi KUTSUNA participated as a short-term consultant to strengthen IPC and Antimicrobial
Stewardship (ASP) in partnership with the Japan International Cooperation Agency (JICA) at Cho Ray
Hospital, Ho Chi Minh City, Vietnam (December 1-5, 2019). He delivered lectures and provided advice on IPC,
clinical management of infections caused by carbapenem-resistant Enterobacteriaceae (CRE), and ASP.
Activity 3
Title: To participate in monitoring and assessments of in-country capacity in relation to IHR core capacities
through APSED
Description: The proposed institution will participate in the monitoring and evaluation activities of IHR
implementation, including the areas of IPC and clinical management component, upon request from the WHO.
Status: ongoing
Dr. Norio Ohmagari attended the Meeting of the Technical Advisory Group on the Antimicrobial Resistance(AMR) at the request of the WHO (July 24-25, 2019, Manila, Philippine). At the meeting, he provided technicaladvice on the planning and implementation of IPC and clinical management components for AMR.
Dr. Masahiro ISHIKANE participated in the WHO joint external evaluation (JEE) mission in Malaysia as a
WHO international member (October 20-25, 2019). He was the leader and co-leader of the antimicrobial
resistance and surveillance teams, respectively. After discussions with the Ministry of Health, Malaysia, hereported on the strengths and challenges experienced in each field.
Dr. Sho SAITO, Dr. Satoshi KUTSUNA, Dr. Shinichiro MORIOKA, and Ms. Sangnim LEE conducted aworkshop on oral care IPC and ASP in Sulilanti Saroso Infectious Diseases Hospital (July 8-11, October 9-13,
2019, Jakarta, Indonesia). They reported improved knowledge levels about hand hygiene and oral careamong the participating health care professionals. All relevant issues related to ASP were also clarified.
Activity 4
Title: To share information and knowledge on best practices of IPC and clinical management of EIDs
Description: NCGM plans to collect and share best practices of IPC and clinical management of emerging
infectious diseases including antimicrobial resistant infections with health care professionals via workshops
and seminars at NCGM.
NCGM will share information of best practices of IPC and clinical management through e-learning and other
online channels.
Status: ongoing
The Disease Control and Prevention Center (DCC) developed teaching materials on IPC and ASP. These
resources focus on hand hygiene, oral care, ASP, ASP team, and prevention of surgical site infection inorthopedics. These materials, which are shared through the DCC website(http://dcc.ncgm.go.jp/en/Activities/040/2019/index.html), are considered useful for resource-limited countries.
Upon request, the DCC can also provide IPC or AMR workshop in the resource-limited and underdeveloped
areas.
Activity 5
Title: To provide technical support in the investigation of EID outbreaks
Description: The proposed institute will provide technical supports in the investigation of emerging infectious
diseases including AMR, upon request from WHO.

5/19/2020 7:09:17 AM

Page (2/5)

Collaborating Centres
ANNUAL REPORT
Status: ongoing
Dr. Satoshi KUTSUNA investigated the Crimean-Congo hemorrhagic fever (CCHF) in Turkey at the request of
the Ministry of Health, Labor, and Welfare (MHLW) of Japan (July 1-6, 2019). He visited the Ankara Yildirim
Beyazit University, the Ankara Training and Research Hospital, and the Ministry of Health. Moreover, he held
discussion with and delivered a lecture on IPC and clinical management of CCHF to the local doctors.
Furthermore, Dr. Satoshi KUTSUNA investigated the outbreak of Ebola virus disease (EVD) in the Democratic
Republic of Congo as one of the members of the Japan Disaster Relief (August 10-26, 2019). He visited the
Health Department in Kisangani city, Province de la Tshopo. In addition to holding discussions with anddelivering a lecture on IPC and clinical management of EVD to the local HCWs, he opened a new local
quarantine station in the area.
Dr. Shinichiro MORIOKA investigated the outbreak of multidrug-resistant Enterobacteriaceae in Papua New
Guinea (September 16-27, 2019), as requested by the WHO Western Pacific Regional Office (WPRO). He
identified the challenges of IPC in health care facilities in Papua New Guinea and reported to the Elias
Kapavore, Minister, Ministry of Health, Papua New Guinea. After discussing the improvement of IPC in the
country and identifying a specific solution, he provided a final draft of a national action plan for mid- to longterm IPC.
Dr. Kei YAMAMOTO investigated the outbreak of measles in infants in the Independent State of Samoa(December 7-21, 2019). As an infectious disease expert, he provided advice on the IPC of antimicrobial
resistance after the measles outbreak. Through environmental rounds and workshop for hand hygiene, hefurther advised the healthcare stakeholders on the improvement of hand hygiene and development of an IPC
system and shared the challenges facing IPC with the Ministry of Health, Independent State of Samoa.
Activity 6
Title: As part of outbreak response, to provide technical assistance in improving IPC and clinical managementof EIDs
Description: The proposed institute will provide on-site or remote technical assistance or training in improving
IPC and clinical management of emerging infectious diseases including AMR, upon request from WHO.
Status: ongoing
The DCC, in collaboration with JICA, provided a workshop on response to pandemic influenza to the medical
doctors in China (December 3-12, 2019, Tokyo, Japan). The DCC delivered a lecture on the medical response
to severe influenza, such as diagnosis, treatment, and prevention. A tour of the hospital designated for
infectious diseases was also conducted.
The DCC collected information on IPC and epidemiology of coronavirus disease 2019 (COVID-19), andshared it with WPRO (January 2020). Dr. Norio OHMAGARI checked the COVID-19 IPC guidelines, whichwere prepared by WPRO.
On 24th March 2020, Dr. Norio OHMAGARI delivered a Webinar lecture on the Japanese COVID-19
experiences, including preparedness, responses, and clinical management at the request of Dr. Masahiro
ZAKOJI, Technical Officer, Department of Health Systems Development, WHO Southeast Asia Regional
Office (SEARO).
2. Annual report on other activities requested
Should WHO have requested activities in addition to the agreed workplan, please describe related
actions taken by your institution [maximum 200 words]. Please do not include in this report any
activity done by your institution thatwas not requested by and agreed with WHO.

5/19/2020 7:09:17 AM

Page (3/5)

Collaborating Centres
ANNUAL REPORTAt the request of HQ, Dr. Norio OHMAGARI participated in the third Antibacterial pipeline advisory groupmeeting (September 30- October 1, 2019, Geneva, Switzerland). He delivered a lecture on the overview of theantibacterial research and development (R&D) landscape in Japan, and discussed the subject withinternational experts. His lecture slide was shared at the DCC website(http://dcc.ncgm.go.jp/en/Activities/040/2019/index.html).
At the request of HQ, Dr. Nobuaki MATSUNAGA and Dr. Norio OHMAGARI evaluated the Global
Antimicrobial Resistance Surveillance System (GLASS) (October 2019). They reviewed WHO GLASS
guidelines on minimal requirements for National Reference Laboratories.

3. Resources
Indicate staff time spent on the implementation of activities agreed with WHO (i.e. those mentioned inquestions no. 1 and no. 2 above). Do not include any data related to other activities done by yourinstitution without the agreement of WHO. Please indicate staff time using the number of “full-day
equivalents” – a day of work comprising 8 hours (e.g. 4 hours work per day for 7 days should berecorded as 3.5 full-day equivalents).
Number of staff involved (either partially or fully)
Senior staff

Mid-career staff

Junior staff, PhD students

4

0

0

Number of full-day equivalents, total for all staff involved
Senior staff

Mid-career staff

Junior staff, PhD students

7

0

0

Implementation of the agreed workplan activities (i.e. those mentioned in questions no. 1 and no. 2
above) normally require resources beyond staff-time, such as the use of laboratory facilities,
purchasing of materials, travel, etc. Please estimate the costs of these other resources as apercentage of the total costs incurred (e.g. if you incurred costs of USD 100 and the value of your staff
time was USD 50 which makes the total of USD 150, please report 33.3% and 66.7%).
Percentage of costs
associated with staff time

Percentage of costs associated with Totalother resources

25.00

75.00

100.004. Networking
Describe any interactions or collaboration with other WHO Collaborating Centres in the context of theimplementation of the agreed activities If you are part of a network of WHO Collaborating Centres,
please also mention the name of the network and describe your involvement in that network[maximum 200 words].

5/19/2020 7:09:17 AM

Page (4/5)

Collaborating Centres
ANNUAL REPORT
Dr. Masahiro ISHIKANE and Ms. Sangnim Lee participated in the first WHO Western Pacific Region Partners’
Web Forum (July 1-3, 2019). At the forum, they discussed the thematic priorities in WPRO to tackle theregion’s current and future big challenges.
Dr. Masahiro ISHIKANE, Dr. Noriko KINOSHITA, and Dr. Nobuaki MATSUNAGA discussed and shared thecurrent situation and experience of antimicrobial resistance with the Ministry of Health, Thailand (TH-71) (July30-August 2, 2019, Bangkok, Thailand). They also discussed one health approach and its relevance toantimicrobial resistance.
Dr. Norio OHMAGARI, Dr. Masahiro ISHIKANE, Dr. Shinichiro MORIOKA, and Ms. Sangnim LEE participatedin the third Japanese WHO Collaborating Centers (WHOCC) meeting (September 6, 2019, Tokyo), which was
also attended by Dr. Takeshi Kasai, Director General, WPRO, and Dr. Shinjiro NOZAKI, Compliance and Risk
Management Officer/Office of the Regional Director, WPRO. Thirty WHOCC with 49 experts from Japan
participated in the meeting. They exchanged information and opinions to promote collaboration andcooperation among WHOCCs.
Dr. Masahiro ISHIKANE participated in the International Forum on Gonococcal Infection and Resistance 2019,at the request of WPRO (September 26-28, 2019, Suzhou, China). This forum was organized mainly by the
National Center for Sexually Transmitted Disease (STD) Control, Chinese Center for Disease Control andPrevention (Chinese CDC), WHOCC for Prevention and Control of Sexually Transmitted Infections (STI)(CHN-75). He shared information on epidemiology, surveillance, risk factors, treatment, and vaccines against
drug-resistant gonorrhea. Dr. Masahiro ISHIKANE also provided insights on the growing network of experts.
The DCC hosted the WHO Global Outbreak Alert and Response Network (GOARN) Tier 1.5 Training
Workshop, which was held for the first time in 10 years in Japan (December 5-6, 2019, Tokyo, Japan). This
workshop was organized in collaboration with Global Health, International Affairs Division, Minister’s
Secretariat and Tuberculosis and Infectious Disease Control Division, Health Service Bureau, Ministry of
Health, Labor, and Welfare, Japan. The participants included three staff members from WHO (Ms. Renee
Christensen, technical officer and GOARN Training Coordinator in WHO, Geneva, Ms. Polly Wallace,epidemiologist based with Australian National University, and Dr. Sharon Salmon, infection Prevention andControl Specialist, WPRO) and 50 health care professionals from Japan. Through the workshop, they
developed a human resource network for international response to disease outbreak.
Dr. Sho SAITO, Dr. Satoshi KUTSUNA, Dr. Shinichiro MORIOKA, and Dr. Masahiro ISHIKANE conducted aworkshop on oral care, IPC, and ASP with Sulilanti Saroso Infectious Diseases Hospital (January 28-31,
Tokyo, Japan). At this workshop, they also collaborated with Niigata University, WHOCC, for the Translation of
Oral Health Science (JPN-75).

5/19/2020 7:09:17 AM

Page (5/5)